Objective:To predict the risk of major adverse cardiovascular events (MACE) in acute coronary syndrome (ACS) patients with Subclinical thyroid function decline through exploration of free triiodothyronine (FT3), cardiac troponin I (cTnI), and N-terminal pro B-type natriuretic peptide (NT-proBNP) .Methods:A retrospective analysis was conducted on medical records of 125 ACS patients with Subclinical thyroid function decline to the Second People’s Hospital of Hefei City from Jan. 2020 to Mar. 2022. On the second day of hospitalization, fasting blood samples were collected from the patients. The levels of cTnI and NT-proBNP were measured using an electrochemiluminescence assay, while the level of FT3 was measured using a radioimmunoassay. The patients were followed up for 3 months to observe and record the occurrence of MACE. Based on the outcomes of MACE, the patients were divided into two groups: the adverse prognosis group and the good prognosis group. Logistic multivariate regression analysis was performed to identify the factors influencing the occurrence of MACE in ACS patients, and the predictive value of serum cTnI, NT-proBNP, and FT3 for MACE occurrence in ACS patients was evaluated.Results:Among the 125 ACS patients with Subclinical thyroid function decline, the incidence of MACE was 36 cases, with an incidence rate of 28.80%. Age ( OR=4.067, 95% CI: 1.856-10.231), hypertension ( OR=4.651, 95% CI: 1.942-9.779), diabetes ( OR=4.358, 95% CI: 1.887-10.051), coronary artery disease involving ≥3 vessels ( OR=4.047, 95% CI: 1.900-9.994), total cholesterol (TC) ( OR=4.100, 95% CI: 1.776-9.462), triglycerides (TG) ( OR=4.162, 95% CI: 1.558 - 11.114), low-density lipoprotein cholesterol (LDL-C) ( OR=3.428, 95% CI:1.642-8.743), serum cTnI ( OR=4.545, 95% CI: 1.987-10.394), and NT-proBNP ( OR=4.660, 95% CI: 2.045-10.617) were identified as risk factors for MACE occurrence ( P<0.05), while serum FT3 ( OR=0.275, 95% CI: 0.119-0.631) was considered a protective factor against MACE occurrence ( P<0.05). The individual and combined predictive values (area under the curve) of serum cTnI, NT-proBNP, and FT3 for MACE occurrence in ACS patients were 0.754, 0.738, 0.741, and 0.829, respectively. Conclusion:Serum cTnI, NT-proBNP, FT3 are closely related to the risk of MACE in patients with acute coronary syndrome with Subclinical thyroid function decline, and have high predic-tive power for the risk of mace.
目的 探讨入院早期序贯器官衰竭估计评分(SOFA)联合红细胞分布宽度(RDW)对急性胰腺炎(AP)短期预后的预测价值.方法 选取合肥市第二人民医院2016年12月—2021年4月收治的79例AP患者作为研究对象,患者入院后,均接受AP相关治疗,根据治疗5 d后的临床疗效,将痊愈、好转患者归入预后良好组(n=65),无效患者归入预后不良组(n=14).比较预后良好组与预后不良组入院早期SOFA评分、RDW等临床资料,多因素Logistic回归分析探讨影响AP患者短期预后的因素,Pearson相关性分析研究入院早期SOFA评分、RDW与急性生理与慢性健康评分(APACHEⅡ)的相关性,受试者工作特征(ROC)曲线评估入院早期SOFA评分、RDW对AP患者短期预后的预测价值.结果 预后不良组APACHEⅡ评分,入院早期SOFA评分,RDW,尿素氮高于预后良好组,血小板计数低于预后良好组(均P<0.05);多因素Logistic回归分析结果显示APACHEⅡ评分,入院早期SOFA评分,RDW是AP预后的独立危险因素(OR=7.114,4.280,2.284,P<0.05);入院早期SOFA评分,RDW均与APACHEⅡ评分正相关(r=0.836,0.594,P<0.05);入院早期SOFA评分、RDW、二者联合预测AP患者短期预后的曲线下面积(AUC)分别为0.761(95%CI=0.617~0.905)、0.701(95%CI=0.523~0.867)、0.785(95%CI=0.750~1.000);入院早期SOFA评分联合RDW的AUC大于单独入院早期SOFA评分、RDW的AUC(P<0.05).结论 治疗无效的AP患者入院早期SOFA评分、RDW更高,入院早期SOFA评分、RDW是AP患者不良临床结局的独立影响因素,在预测患者短期预后中具有较高价值.
目的:探讨维生素C辅助奥曲肽治疗急性胰腺炎(AP)患者对肠黏膜屏障功能和外周血T淋巴细胞亚群的影响.方法:选取2020年1月~2022年1月安徽省合肥市第二人民医院收治的65例AP患者作为研究对象,使用信封法将其随机分为试验组(33例)和对照组(32例).对照组予以奥曲肽+常规治疗,试验组在对照组治疗基础上,另予维生素C治疗.比较两组患者治疗后胃肠功能恢复指标、治疗前后肠黏膜屏障功能和外周血T淋巴细胞亚群指标及不良反应.结果:治疗后,试验组患者腹痛消失时间、呕吐缓解时间、肠鸣音复常时间和肛门首次排气时间均明显少于对照组(P<0.05),且内毒素、二胺氧化酶(DAO)及D-乳酸水平均低于明显低于对照组(P<0.05);试验组CD8+明显水平低于对照组(P<0.05),而CD4+水平及CD4+/CD8+均显著高于对照组(P<0.05);试验组不良反应发生率(18.18%)与对照组(12.50%)无显著性差异(P>0.05).结论:使用维生素C辅助奥曲肽治疗AP患者,可有效改善肠黏膜屏障功能和外周血T淋巴细胞亚群指标,安全性高.
目的:探讨平均血小板体积与淋巴细胞比值(mean platelet volume to lymphocyte ratio,MPVLR)、格拉斯哥预后评分(Glasgow prognosis score,Glasgow)与急性冠脉综合征患者经皮冠状动脉介入治疗(percutaneous coronary intervention,PCI)术后预后的关系.方法:选取2019年1月至2021年7月在我院治疗的急性冠脉综合征患者98例,根据术后1年是否发生心源性或全因死亡、急性心力衰竭等主要不良心血管事件(major adverse cardiovascular events,MACE)分为预后不良组和预后良好组,分别为30例和68例,观察比较预后不良和良好组患者GRACE评分、Glasgow评分、MPVLR等临床资料等差异.结果:预后不良组患者入院GRACE评分为(145.50±19.29)分,明显高于预后良好组患者(P<0.05);预后不良组患者Glasgow评分1~2分比例为80.00%,明显高于预后良好组患者(P<0.05);预后不良组患者MPVLR和肌钙蛋白T(cardiac troponin T,cTnT)峰值分别为(6.90±1.01)和(6.69±1.32)ng/mL,明显高于预后良好组患者(P<0.05);预后不良组患者左室射血分数(left ventricular ejection frac-tion,LVEF)为(46.60±7.82)%,明显低于预后良好组患者(P<0.05);Logistic回归分析显示:Glasgow评分、MPVLR及LVEF是急性冠脉综合征患者PCI术后预后不良的影响因素(P<0.05).结论:入院时MPVLR、Glasgow评分与急性冠脉综合征患者PCI术后预后不良有关,值得进一步研究.
目的 探索合并代谢综合征(Metabolic syndrome,MS)的轻中度急性胰腺炎(Acute pancreatitis,AP)患者的临床特点及影响短期复发的危险因素.方法 回顾性收集2020年1月至2021年9月期间合肥市第二人民医院急诊科收治的282例轻中度AP患者的临床数据,包括一般资料、APACHE-Ⅱ评分、sofa评分、CT分级、实验室检查等,根据是否合并代谢综合征分为MS组和NMS组,所有患者均接受相似的保守治疗,观察两组患者的临床特点.通过随访了解患者1年内的复发情况,使用logistic回归分析探索影响轻中度AP患者短期复发的危险因素.结果 与NMS组相比,合并MS的患者男性占比更高,年龄较低,BMI、血糖和血脂更高,高血压、糖尿病等慢性病史占比高,吸烟史和饮酒史更多,胆源性病因较少,且CT分级更高(P<0.05).糖尿病病史、饮酒史、CT分级为D级、胆源性病因以及甘油三酯异常升高是影响轻中度AP患者短期复发的独立危险因素.结论 合并MS的轻中度AP患者病情较NMS的患者更重,CT分级更高,会提高短期复发的风险,提前关注这类患者有助于在临床工作中早期干预以降低短期复发的风险.
目的 探讨急性胰腺炎(acute pancreatitis,AP)合并糖尿病酮症酸中毒(diabetic ketoacidosis,DKA)的临床预后影响因素.方法 选取2017年1月至2020年12月期间于我院就诊的58例AP合并DKA患者为研究对象,根据预后分为死亡组与存活组.比较两组临床资料,采用多因素logistics回归分析筛选出死亡发生的独立影响因素.结果 全部58例患者共有15例患者死亡,病死率为25.9%,归为死亡组,其余43例患者归为存活组.死亡组患者的年龄、入院时的血甘油三酯(triglyceride,TG)、超敏C反应蛋白、入院后24h的休克、感染发生率及序贯性器官功能衰竭评分(Sequential Organ Failure As-sessment,SOFA)显著高于存活组,血钠、钙、血pH值显著低于存活组,差异有统计学意义(P<0.05).多因素logistic回归分析结果表明入院时的血TG、钙水平、入院后24h的SOFA评分是死亡发生的独立影响因素(P<0.05).结论 AP合并DKA患者的临床整体预后并不理想,入院时的血TG、钙水平、入院后24h的SOFA评分是患者死亡发生的独立影响因素.
Objective:To explore the effect of large-volume versus restrictive fluid resuscitation on hemodynamics and prognosis in patients with severe acute pancreatitis (SAP). Methods:A total of 102 patients with severe acute pancreatitis who received treatment in The Second People's Hospital of Hefei, China between March 2018 and December 2020 were included in this study. They were randomly assigned to undergo large-volume fluid resuscitation (control group, n = 51) or restrictive-volume fluid resuscitation (study group, n = 51). Hemodynamic indexes, intra-abdominal pressure and pulmonary function were compared between the two groups before and after resuscitation. All patients were followed up for 28 days after admission and their prognosis was recorded. Results:At 12 and 24 hours of resuscitation, intrathoracic blood volume index, global end-diastolic volume index, cardiac index, and central venous pressure in the study group were significantly higher than those in the control group (all P < 0.05). At 6 hours of resuscitation, cardiac index and central venous pressure in the study group were (4.87 ± 0.48) and (11.04 ± 2.08), respectively, which were significantly higher than those in the control group [(4.53 ± 0.57), (9.48 ± 1.67), t = 3.25, 4.17, both P < 0.05). Before resuscitation, there was no significant difference in intra-abdominal pressure between the two groups ( P > 0.05). After resuscitation, intra-abdominal pressure in each group was significantly lower compared with that before resuscitation (both P < 0.05). After resuscitation, intra-abdominal pressure in the study group was significantly lower than that in the control group [(12.78 ± 2.35) cmH 2O vs. (15.01 ± 2.42) cmH 2O, t = 4.72, P < 0.05). Before resuscitation, there were no significant differences in PaO 2 and oxygenation index between two groups (both P < 0.05). After resuscitation, PaO 2 and oxygenation index in each group were significantly higher compared with those before resuscitation (both P < 0.05). After resuscitation, PaO 2 and oxygenation index in the study group were significantly higher than those in the control group ( t = 3.02, 5.55, both P < 0.05). The incidence of abdominal compartment syndrome and the incidence of invasive mechanical ventilation in the study group were 27.45% (14/51) and 35.29% (18/51), respectively, which were significantly lower than those in the control group [47.06% (24/51), 56.86% (29/51), χ 2 = 4.19, 4.77, both P < 0.05). There were no significant differences in the incidence of multiple organ dysfunction syndrome, acute renal injury, abdominal drainage rate, mortality between the two groups (all P > 0.05). Conclusion:Compared with large-volume fluid resuscitation, restrictive-volume fluid resuscitation can better improve hemodynamic indexes and pulmonary function, greatly decrease intra-abdominal pressure, and improve prognosis in patients with severe acute pancreatitis.
目的:研究电子计算机断层扫描(CT)影像在重症急性胰腺炎(SAP)早期肠内营养中的应用效果.方法:选择我院于2018年12月~2021年12月期间收治的50例SAP患者为研究对象,根据治疗方式分为两组,对照组行常规治疗,观察组在对照组基础上结合早期肠内营养支持,同时两组均进行CT检查,比较分析两组胰腺密度变化情况及CTSI评分、炎症因子变化情况及并发症发生情况.结果:两组胰腺密度均提高,观察组更密(P<0.05);治疗后两组CRP、IL-6、TNF-α数值、CTSI评分降低,观察组数值更低,且并发率小于对照组(P<0.05).结论:针对SAP患者实施肠内营养治疗效果显著,通过CT影像提高了临床诊断效果,能够减轻机炎症反应,加快身体康复,值得临床应用.
目的 探究缺血修饰白蛋白(IMA)与超敏肌钙蛋白(hs-cTnI)联合检测对急性重度有机磷农药中毒继发心脏损害的预测价值.方法 选取合肥市第二人民医院2019年7月—2021年5月收治的84例急性重度有机磷农药中毒患者作为研究对象,收集并整理患者入院后的相关病历资料,分别采用全自动生化分析仪及白蛋白钴结合试验(ACB)检测患者入院时的hs-cTnI及IMA水平.根据患者治疗后1周内是否出现心脏损伤事件将其分为心脏损害组及心脏未损害组,以Logistic多因素回归分析探讨影响急性重度有机磷农药中毒患者继发心脏损害的相关因素,以受试者工作特征曲线(ROC)判定hs-cTnI及血清IMA对急性重度有机磷农药中毒患者继发心脏损害的预测价值.结果 本研究84例急性重度有机磷农药中毒患者中,20例患者继发心脏损害(23.81%),64例患者未继发心脏损害(76.19%).心脏损害组血清TC、血清TG、血清Lac、hs-cTnI及血清IMA水平均高于心脏未损害组(P<0.05).多因素回归分析结果显示,血清TC、血清TG、血清Lac、hs-cTnI及血清IMA表达水平偏高均为急性重度有机磷农药中毒患者继发心脏损害的危险因素(P<0.05).ROC分析显示,hs-cTnI及血清IMA水平单一及联合预测急性重度有机磷农药中毒患者继发心脏损害的曲线下面积(AUC)分别为0.795、0.734、0.865.hs-cTnI及血清IMA水平单一对急性重度有机磷农药中毒患者继发心脏损害的预测效能低于两者联合(P<0.05).结论 血清hs-cTnI及血清IMA表达水平升高的急性重度有机磷农药中毒患者更易继发心脏损害,且hs-cTnI及血清IMA水平可作为预测急性重度有机磷农药中毒患者继发心脏损害的参考指标.
目的 研究血清α-黑色素细胞刺激素(α-MSH)和单核细胞趋化蛋白1(MCP-1)对急性胰腺炎(AP)严重程度早期评估及预后的预测价值.方法 选取2019年12月—2021年12月合肥市第二人民医院/安徽医科大学附属合肥医院急诊科诊治AP患者117例,入院时根据病情严重程度分为轻型胰腺炎(MAP)45例、中度重症胰腺炎(MSAP)38例、重症胰腺炎(SAP)34例,并根据28 d内病死情况分为病死组11例与生存组106例.检测并比较不同严重程度及不同预后AP患者血清α-MSH、MCP-1水平,Spearman分析血清α-MSH、MCP-1与AP严重程度的相关性,Logistic回归分析AP患者预后的影响因素,受试者工作特征曲线(ROC)分析血清α-MSH、MCP-1对AP患者预后的预测价值.结果 病死组入院当天胸腔积液占比、SAP占比高于生存组(χ2/P=4.193/0.041、2.691/0.007);病死组血清α-MSH水平低于生存组,MCP-1水平高于生存组(t/P=12.072/<0.001、6.390/<0.001);血清α-MSH水平比较,MAP>MSAP>SAP(F/P=261.462/<0.001),而MCP-1水平比较,MAP
It has been suggested that organophosphate pesticides can cause cognitive impairment, most of which are presented as mild cognitive impairment such as decreased attention or vigilance, reduced information processing speed and memory impairment. An early diagnosis and timely intervention in mild cognitive impairment, which may provide a better prognosis. Mild cognitive impairment in clinical work can be easily ignored for a long time. However, it have a particularly impact on patients' life and work, and even progress to irreversible neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. Therefore, clinicians should raise the cognition of organophosphate pesticides poisoning in patients with cognitive impairment, especially for patients with mild cognitive impairment, and the significance of early detection and diagnosis of the disease is particularly important.
目的 观察血液净化联合氯解磷定在急性重症有机磷农药中毒(ASOPP)的疗效及对血清单核细胞趋化蛋白-1(MCP-1)的影响.方法 84例ASOPP患者依据随机数字表法分为对照组和观察组,各42例.给予对照组肌肉注射氯解磷定,给予观察组肌肉注射氯解磷定联合血液净化治疗.比较两组疗效、病死率、昏迷至清醒时间、ChE活性恢复正常时间、住院天数、并发症情况和治疗前后血清MCP-1水平.结果 观察组总有效率(95.24%vs.80.95%)明显高于对照组,多器官损伤发生率(11.90%vs.38.09%)明显低于对照组(χ2=4.086、4.766,P<0.05).观察组清醒时间[(1.82±0.67)h vs.(3.65±1.26)h]、机械通气时间[(3.28±1.18)h vs.(6.49±2.04)h]、ChE活性恢复正常时间[(3.97±1.43)d vs.(8.71±2.32)d]和住院天数[(10.76±1.92)d vs.(16.35±3.25)d]均明显短于对照组(t=8.311、8.827、11.272、9.598,P<0.05).观察组治疗后血清MCP-1水平明显低于对照组[(84.54±14.32)pg/ml vs.(132.59±19.24)pg/ml,t=13.706,P<0.05].结论 血液净化联合氯解磷定能够显著降低ASOPP患者病死率、加快症状改善,减少并发症.
Objective:To explore the predictive value of different scoring methods for the prognosis of patients with hyperthermia.Methods:In September 2019, the clinical data of 49 patients with heat radiation disease in the second people's Hospital of Hefei were collected retrospectively. According to the prognosis of patients, they were divided into survival group (32 cases) and death group (17 cases) . The rapid emergency medicine score (REMS) , modified early warning score (modified early warning score) were calculated respectively Score (mews) , logistic organ dysfunction system (LODs) and the differences between the two groups were compared. ROC curve was used to evaluate the accuracy of various scores in the prognosis of patients with heat radiation disease.Results:the fatality of heat stroke was 34.69%, there were significant differences of REMS, MEWS and LODS between the two groups ( P<0.05) , the area under ROC curve (AUC) of REMS, MEWS and LODS to predicting prognosis of heat stroke was (0.696±0.076, 95% CI: 0.548 to 0.844, P<0.05, 0.692±0.079, 95% CI: 0.536 to 0.848, P<0.05, 0.787±0.063, 95% CI: 0.663 to 0.911, P<0.05) respectively. Conclusion:There are valuable for predicting prognosis of patients with heat stroke by REMS, MEWS and LODS, especially the LODS, the REMS and MEWS are simple and easy.
目的:探讨加贝酯联合生长抑素治疗胰腺炎近期疗效及对炎症因子、D-乳酸的影响.方法:选择2017年1月至2010年1月在我院接受治疗的急性胰腺炎患者80例为研究对象,按照随机数表法分为对照组(n=40)和试验组(n=40).对照组采用生长抑素治疗,实验组采用加贝酯联合生长抑素治疗,比较两组临床疗效、腹部体征与胃肠道功能恢复时间、血清CRP、TNF-α、IL-6、D-乳酸水平及血淀粉酶、尿淀粉酶、脂肪酶水平.并统计两组不良反应发生情况.结果:试验组组总有效率为75.00%(30/40),试验组总有效率为92.50%(37/40),两组比较有统计学意义(P<0.05).试验组腹部体征消失时间及胃肠道功能恢复时间均明显短于对照组,差异有统计学意义(P<0.05).治疗前,两组CRP、TNF-α、IL-6、D-乳酸水平及血淀粉酶、尿淀粉酶、脂肪酶水平比较无统计学差异(P>0.05);治疗后,试验组血清CRP、TNF-α、IL-6、D-乳酸水平及血淀粉酶、尿淀粉酶、脂肪酶水平均明显低于对照组(P<0.05).两组患者均发生不同程度的多器官功能衰竭、假性囊肿已经胰周感染,其试验组发生率为7.5%(3/40),对照组发生率为17.5%(7/40),两组比较具有统计学意义(P<0.05).结论:加贝酯联合生长抑素治疗胰腺炎可有效改善患者炎症因子水平及肠粘膜功能,更利于快速控制病情,从而显著提高临床疗效.
目的 探讨颈动脉硬化患者发生心脑血管事件的危险因素.方法 选取2014年1月至2016年12月在合肥市第二人民医院住院发现颈动脉硬化的104例患者,所有患者均自2017年1月随访至2019年6月,将发生心脑血管事件者作为观察组(47例),未发生者为对照组(57例),比较两组患者实验室检查指标,探讨颈动脉硬化患者发生心脑血管事件的危险因素.结果 观察组患者的中性粒细胞/淋巴细胞比值(NLR)、糖尿病及高血压发病率、年龄均高于对照组,差异有统计学意义(P<0.05).lo-gistic回归分析结果 显示,NLR、糖尿病、高血压、年龄为颈动脉硬化患者心脑血管事件发生的危险因素(P<0.05).结论 糖尿病、高血压、高龄、高NLR的颈动脉硬化患者容易发生心脑血管事件,临床应积极干预.
目的 探讨急性缺血性脑卒中(AIS)患者血清学标志物的表达情况,为AIS的诊断和治疗提供依据.方法 回顾性分析91例出现院前卒中症状的患者,根据诊断分为急性期和非急性期缺血性脑卒中,进行统计学分析.结果 单因素分析显示,两组间患者的D-二聚体、血糖、LDL-C、HDL-C的表达差异有统计学意义,多因素回归分析显示,LDL-C、HDL-C在两组患者的表达差异有统计学意义.结论 AIS患者血清学指标二聚体、血糖、LDL-C水平升高、HDL-C水平降低,并且LDL-C、HDL-C为AIS发病的独立风险因素.
目的:分析急诊多发伤患者死亡的相关因素及独立危险因素.方法:回顾性分析我院急诊科2017-01-2018-12期间救治的670例多发伤患者(其中46例死亡)的临床资料,根据患者的预后分为死亡组(46例),同时随机抽取同期多发伤生存患者60例(生存组),对2组患者性别、年龄、致伤原因、受伤部位,受伤至就诊时间、损伤程度评分法(ISS)评分、创伤数量、是否休克、输血量等指标进行比较,并采用Logistic回归分析患者死亡的独立危险因素.结果:死亡组在年龄≥60岁、高处坠落及车祸、颅脑损伤、受伤至就诊时间≥3h、ISS评分≥16分、创伤数量≥4处、休克、输血量≥4U的比例均高于生存组(均P<0.05).其中,患者年龄≥60岁、受伤部位(颅脑)、受伤至就诊时间≥3h、ISS评分≥16分、休克为多发伤病患急诊死亡的独立危险因素.结论:上述独立危险因素应引起急诊医生的重点关注,并以此为依据制定急救预案可以降低多发伤患者的病死率.
目的 探讨急性胰腺炎严重程度床边指数(BISAP)评分、CT严重指数(CTSI)评分用于判断急性胰腺炎(AP)病情的临床价值.方法 选取我院2016年1月-2018年8月确诊的SAP患者70例,根据病情分为重症急性胰腺炎患者24例(SAP组)、轻症急性胰腺炎患者46例(MAP组);对两组患者入院后第1、3、7、14天的BISAP评分、CTSI评分进行评价,并采用受试者工作曲线(ROC)分析BISAP评分、CTSI评分鉴别诊断胰腺炎病情的价值.结果 SAP组患者的BISAP评分和CTSI评分在入院后第1、3、7、14天均显著高于MAP组,差异有统计学意义(P<0.05);BISAP评分、CTSI评分鉴别诊断MAP和SAP的的ROC曲线下AUC值分别为0.774、0.705.结论 入院时AP患者的BISAP评分、CTSI评分对于评价患者的病情严重程度及其变化具有重要的临床价值.
目的:探讨对急性胰腺炎患者进行急诊综合治疗的临床效果.方法:将2017年1月至2018年1月期间安徽省合肥市第二人民医院收治的86例急性胰腺炎患者分为reference组和observation组,每组各有43例患者.对reference组患者进行急诊常规治疗,对observation组患者进行急诊综合治疗.然后,比较两组患者的治疗效果及其各项临床指标.结果:治疗后,与reference组患者相比,observation组患者治疗的总有效率更高,其血淀粉酶水平恢复正常的时间、腹胀消失的时间、腹痛消失的时间和发热消失的时间均更短,P﹤0.05.结论:对急性胰腺炎患者进行急诊综合治疗的效果显著,可有效地促进其身体的恢复.
目的:探讨对急性阑尾炎患者施行微创小切口阑尾切除术的临床效果.方法:将2015年5月至2016年7月合肥市第二人民医院收治的68例阑尾炎患者采用随机数表法分为对照A组与对照B组.为对照B组患者采用传统阑尾切除术进行治疗,为对照A组患者采用微创小切口阑尾切除术进行治疗,然后对比观察两组患者手术的时间、术毕至排气的时间、住院的时间及在术后发生切口感染、肠梗阻等并发症的情况.结果:与对照B组患者相比,对照A组患者手术的时间、术毕至排气的时间及住院的时间均较短,P<0.05.两组患者在进行手术治疗后均未发生切口感染及肠梗阻等并发症.结论:对急性阑尾炎患者施行微创小切口阑尾切除术的安全性较高,可促使其在术后较快的康复.